Sichuan Kelun Pharmaceutical Co Ltd (002422) - Cash Flow Conversion Efficiency

Latest as of September 2025: 0.019x

Based on the latest financial reports, Sichuan Kelun Pharmaceutical Co Ltd (002422) has a cash flow conversion efficiency ratio of 0.019x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥537.31 Million ≈ $78.62 Million USD) by net assets (CN¥28.62 Billion ≈ $4.19 Billion USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Check 002422 PP&E to net assets ratio to assess the company's strategic physical and investment asset allocation.

Sichuan Kelun Pharmaceutical Co Ltd - Cash Flow Conversion Efficiency Trend (2007–2025)

This chart illustrates how Sichuan Kelun Pharmaceutical Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. See Sichuan Kelun Pharmaceutical Co Ltd shareholders equity for net asset value and shareholders' equity analysis.

Sichuan Kelun Pharmaceutical Co Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Sichuan Kelun Pharmaceutical Co Ltd ranked by their cash flow conversion efficiency.

Company Cash Flow Conversion Efficiency
ORION CORP.B UNSP.ADR 1/2
F:OFK0
0.033x
SAINSBURY -J.- ADR/4 NEW
F:SUY
N/A
SPIE SA
PA:SPIE
0.362x
Builders FirstSource Inc
NYSE:BLDR
0.022x
Bharti Hexacom Ltd
NSE:BHARTIHEXA
0.173x
GETLINK ADR EO-40
F:TNU
N/A
Yanzhou Coal Mining Company Limited
F:YZC
0.000x
BlueFocus Communication Group
SHE:300058
0.064x

Annual Cash Flow Conversion Efficiency for Sichuan Kelun Pharmaceutical Co Ltd (2007–2025)

The table below shows the annual cash flow conversion efficiency of Sichuan Kelun Pharmaceutical Co Ltd from 2007 to 2025. For the full company profile with market capitalisation and key ratios, see Sichuan Kelun Pharmaceutical Co Ltd (002422) market capitalisation.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 CN¥29.29 Billion
≈ $4.29 Billion
CN¥2.64 Billion
≈ $386.62 Million
0.090x -46.32%
2024-12-31 CN¥26.74 Billion
≈ $3.91 Billion
CN¥4.49 Billion
≈ $657.45 Million
0.168x -27.54%
2023-12-31 CN¥23.02 Billion
≈ $3.37 Billion
CN¥5.34 Billion
≈ $780.98 Million
0.232x +25.09%
2022-12-31 CN¥16.87 Billion
≈ $2.47 Billion
CN¥3.13 Billion
≈ $457.65 Million
0.185x -8.00%
2021-12-31 CN¥14.13 Billion
≈ $2.07 Billion
CN¥2.85 Billion
≈ $416.62 Million
0.202x +27.14%
2020-12-31 CN¥14.00 Billion
≈ $2.05 Billion
CN¥2.22 Billion
≈ $324.77 Million
0.158x -0.58%
2019-12-31 CN¥13.91 Billion
≈ $2.03 Billion
CN¥2.22 Billion
≈ $324.38 Million
0.159x -30.12%
2018-12-31 CN¥12.95 Billion
≈ $1.89 Billion
CN¥2.95 Billion
≈ $432.19 Million
0.228x +127.17%
2017-12-31 CN¥11.98 Billion
≈ $1.75 Billion
CN¥1.20 Billion
≈ $176.06 Million
0.100x -33.27%
2016-12-31 CN¥11.47 Billion
≈ $1.68 Billion
CN¥1.73 Billion
≈ $252.48 Million
0.150x +35.54%
2015-12-31 CN¥11.16 Billion
≈ $1.63 Billion
CN¥1.24 Billion
≈ $181.37 Million
0.111x -0.06%
2014-12-31 CN¥10.97 Billion
≈ $1.61 Billion
CN¥1.22 Billion
≈ $178.34 Million
0.111x +6.02%
2013-12-31 CN¥10.02 Billion
≈ $1.47 Billion
CN¥1.05 Billion
≈ $153.70 Million
0.105x +135.82%
2012-12-31 CN¥9.06 Billion
≈ $1.33 Billion
CN¥402.77 Million
≈ $58.94 Million
0.044x +2.77%
2011-12-31 CN¥7.93 Billion
≈ $1.16 Billion
CN¥342.93 Million
≈ $50.18 Million
0.043x +104.24%
2010-12-31 CN¥7.05 Billion
≈ $1.03 Billion
CN¥149.29 Million
≈ $21.85 Million
0.021x -86.66%
2009-12-31 CN¥1.58 Billion
≈ $231.12 Million
CN¥250.69 Million
≈ $36.68 Million
0.159x -14.55%
2008-12-31 CN¥1.19 Billion
≈ $174.17 Million
CN¥221.08 Million
≈ $32.35 Million
0.186x -23.77%
2007-12-31 CN¥691.22 Million
≈ $101.15 Million
CN¥168.42 Million
≈ $24.65 Million
0.244x --

About Sichuan Kelun Pharmaceutical Co Ltd

SHE:002422 China Drug Manufacturers - General
Market Cap
$8.31 Billion
CN¥56.76 Billion CNY
Market Cap Rank
#2600 Global
#332 in China
Share Price
CN¥35.68
Change (1 day)
+1.28%
52-Week Range
CN¥28.83 - CN¥40.70
All Time High
CN¥40.70
About

Sichuan Kelun Pharmaceutical Co., Ltd. researches, develops, produces, and sells infusion and non-infusion pharmaceutical products in China and internationally. The company operates through Chuanning, Botai, and Other Business segments. The company offers infusion products; oral medication and other dosage form; medical devices, such as infusion sets, sterile dispensing and injection syringes, ve… Read more